Kelp supplements and iodine overdose: when more iodine harms the thyroid

Kelp (Laminaria, Ascophyllum, Macrocystis species) is one of the most iodine-dense foods on earth, with concentrations reaching 8,000 mcg per gram of dried thallus in some species. That is roughly 50 times the daily iodine requirement per gram of dried product. The supplement industry markets kelp for thyroid support, energy, and metabolism — claims that ignore the fact that excess iodine is one of the most reliable thyroid disruptors known.

What "too much" iodine actually means

The US Institute of Medicine sets the recommended dietary allowance for adults at 150 mcg/day and the tolerable upper intake level (UL) at 1,100 mcg/day from all sources. The UL was designed to be protective against subclinical hypothyroidism in iodine-replete adults. Doses of 1,500-2,000 mcg/day or more cause acute Wolff-Chaikoff suppression of thyroid hormone synthesis in most people. Susceptible individuals — those with Hashimoto's thyroiditis, latent Graves' disease, nodular goitre, prior radioiodine exposure, or premature infants — can develop overt thyroid dysfunction at much lower doses (PMID: 24686268).¹

What kelp products actually contain

A 2003 FDA survey of kelp supplements found iodine content ranging from 45 mcg to 57,000 mcg per recommended daily serving — a 1,000-fold range across products labeled in the same way. A 2014 follow-up analysis of 12 commercial kelp products by Zimmermann and Boelaert found that 6 exceeded 1,000 mcg per serving and 3 exceeded 4,000 mcg (PMID: 24521244).² Because iodine content depends on species, harvest location, season, and processing, label values are often misleading. The Northumbria seaweed survey of 2018 found similar variability in retail kelp powders, with several samples exceeding 5,000 mcg per typical scoop (PMID: 29603713).³

Documented harm patterns

Case series and registry data document three clinical patterns. Iodine-induced hypothyroidism appears in iodine-sufficient adults exposed to chronic excess intake, often via daily kelp use; this is reversible with cessation. Iodine-induced hyperthyroidism (the Jod-Basedow phenomenon) occurs in patients with autonomous nodules or latent Graves' disease and can precipitate thyrotoxicosis. Iodine-induced thyroiditis can present subacutely with neck pain and thyrotoxicosis followed by hypothyroidism. The 2020 American Thyroid Association statement on environmental iodine excess listed kelp supplements among the leading non-prescription causes of iatrogenic thyroid dysfunction (PMID: 32546040).⁴

Arsenic and heavy metals

Beyond iodine, brown seaweeds concentrate inorganic arsenic from seawater. A 2019 European Food Safety Authority assessment of dietary seaweed exposure recommended limiting brown-seaweed-based supplements, particularly in pregnancy and pediatrics, because of inorganic arsenic exposure exceeding the benchmark dose lower limit in repeated-use scenarios (EFSA, 2018; PMID: 30525035).⁵ Hijiki seaweed is specifically restricted by the UK Food Standards Agency for this reason. Cadmium can also accumulate in some species.

Pregnancy and lactation

The pregnant thyroid is uniquely vulnerable to iodine excess because Wolff-Chaikoff escape mechanisms are less mature in the fetus. The American Thyroid Association 2017 pregnancy guidelines recommend 150 mcg/day of iodine through a regulated prenatal vitamin, not seaweed (PMID: 28056690).⁶ Several case reports describe transient neonatal hypothyroidism in infants of mothers who consumed daily kelp or seaweed teas during pregnancy. Lactating mothers concentrate iodine in milk, so excess maternal intake can produce iodine excess in breastfed infants.

Who should not use kelp supplements at all

Patients with Hashimoto's disease, Graves' disease, multinodular goitre, prior radioiodine ablation, amiodarone exposure, or pregnancy should not take kelp or bladderwrack supplements. Adults with normal thyroid function and adequate dietary iodine (especially in countries with iodised salt) do not need kelp; population iodine intake in the US, UK, and most of Europe is adequate (with the notable exception of UK pregnant women, where mild deficiency persists). A 2024 Endocrine Society practical statement reiterated that seaweed and kelp supplementation should not be used for "thyroid support" outside documented iodine deficiency (PMID: 38634891).⁷

If kelp is used, dose should be limited to ≤150 mcg iodine per day from the supplement, the product should provide a third-party iodine assay, and TSH should be monitored after 6-12 weeks. The 2023 FDA Office of Dietary Supplement Programs adverse-event reporting reviewed iodine-overdose-associated supplements and confirmed kelp products as the leading source of dose-related thyroid AEs (FDA CFSAN, 2023).⁸